Toxic Exposure and Asbestos Lawsuit Funding: How to Get Cash While Your Mesothelioma or Environmental Illness Case Is Pending

Toxic exposure lawsuits, also called toxic tort cases, arise when a person suffers illness or injury after being exposed to a dangerous substance. Unlike a car accident where the harm is immediate and visible, toxic exposure cases often involve diseases that develop slowly over months, years, or even decades after the original exposure. This delayed onset makes these cases legally complex, scientifically intensive, and emotionally exhausting for everyone involved.

The most well-known toxic exposure cases involve asbestos. Mesothelioma, a rare and aggressive cancer that affects the lining of the lungs and abdomen, is almost exclusively caused by asbestos exposure. Workers in shipyards, construction, automotive repair, and industrial manufacturing have historically faced the highest risk. Despite asbestos being heavily restricted in the United States, new mesothelioma diagnoses continue to emerge because the disease has a latency period of 20 to 50 years from the time of first exposure.

But asbestos is just one category. Modern toxic tort litigation also covers PFAS (per- and polyfluoroalkyl substances, often called "forever chemicals") contaminating public drinking water near military bases and industrial sites; benzene exposure at oil refineries and chemical plants; lead paint poisoning in older residential buildings; agricultural pesticide exposure among farmworkers; and contaminated water at military installations like Camp Lejeune. In every one of these cases, the plaintiff faces two simultaneous battles: a fight for justice against a well-funded corporate or government defendant, and a prolonged period of financial uncertainty while the legal process unfolds at its own pace.

One of the defining characteristics of toxic exposure litigation is its duration. A straightforward car accident case might resolve in 12 to 18 months. A toxic tort case involving a rare illness, corporate defendants with enormous legal resources, and complex scientific and medical evidence can take anywhere from two to seven years. Some Camp Lejeune claims filed under the 2022 PACT Act are not expected to reach individual resolution for years yet. In federal multidistrict litigation (MDL) proceedings, individual plaintiffs are frequently waiting on the outcome of bellwether trials before their own cases can advance.

During this time, plaintiffs are often dealing with severe illness, ongoing medical treatment, mounting out-of-pocket costs, and the loss of income from being unable to work. Even with health insurance, cancer treatment for mesothelioma or a blood disorder caused by benzene exposure can cost tens of thousands of dollars per year in deductibles, copays, travel to specialists, and non-covered therapies. The financial erosion is steady and relentless.

The defendants in these cases -- typically large corporations with in-house legal departments and experienced outside counsel -- understand this dynamic well. They know that financial desperation works in their favor. The longer a case drags on, the more likely a seriously ill plaintiff is to accept a settlement worth a fraction of the case's true value, just to end the uncertainty and access some cash. Pre-settlement funding exists precisely to counter this pressure. When a plaintiff has financial runway to cover basic living expenses, they do not have to accept an inadequate offer. They can give their attorney the time needed to build the strongest possible case and negotiate from a position of stability rather than desperation.

Pre-settlement funding companies evaluate cases based on individual merits and the likelihood of a meaningful recovery. That said, certain toxic tort categories consistently qualify because they involve clear liability, documented causation, and settlement ranges that support a worthwhile advance.

Mesothelioma and Asbestos Cases: These are among the strongest candidates across all of pre-settlement funding. Mesothelioma settlements regularly range from $1 million to $2.4 million, with jury verdicts sometimes exceeding those figures. Liability is often well-established because internal corporate records from asbestos manufacturers have been widely produced in litigation, demonstrating that companies knew about the health risks and concealed them for decades. Funding amounts for mesothelioma cases can be substantial precisely because the likely recovery supports a larger advance.

PFAS and Contaminated Water Cases: Thousands of individual and municipal lawsuits have been filed over PFAS contamination in drinking water near industrial sites and military installations. Major manufacturers have reached multi-billion dollar global settlements. Individual plaintiffs may qualify for funding while waiting for their specific allocation from a settlement fund or while their individual case continues through the courts.

Benzene and Chemical Exposure Cases: Workers exposed to benzene at refineries, chemical plants, or through the occupational use of benzene-containing products may develop leukemia, myelodysplastic syndrome (MDS), and other serious blood disorders. When medical records document the diagnosis and employment records confirm the exposure history, these cases can be strong on liability and suitable for funding approval.

Lead Paint Poisoning: Children and adults who suffered neurological damage from lead paint in older buildings may have claims against landlords, property managers, or building owners for failure to disclose or remediate a known hazard. Documented cognitive harm carries significant damages potential and can support a funding application.

Camp Lejeune Contamination: Veterans, civilian workers, and family members who lived or worked at Camp Lejeune between August 1953 and December 1987 were exposed to contaminated drinking water linked to cancers, Parkinson's disease, and other serious conditions. The federal claims process under the PACT Act is slow, but legislative recognition of the harm makes these cases fundable when supported by medical and service documentation.

There is a particular injustice built into toxic exposure cases: they disproportionately affect working-class people who spent their careers in physically demanding industries. Shipyard workers, pipefitters, insulators, factory workers, and military veterans built their financial lives around steady employment and employer-provided health coverage. When a serious illness takes away the ability to work, the financial collapse can be rapid and devastating.

Consider a concrete example. A 63-year-old former Navy machinist is diagnosed with mesothelioma. He has solid liability evidence and an experienced attorney who believes the case is worth $1.2 million. But the case will take two to three years to resolve. In the meantime, he is too ill to work, his wife has stepped back from her part-time job to serve as his caregiver, and their combined income has dropped to Social Security payments. Medical bills, even with Medicare, are running $2,000 per month out of pocket. Mortgage payments, utilities, and groceries do not pause for litigation.

Without any financial relief, this plaintiff faces a bleak choice: deplete all savings and retirement assets while waiting for a fair settlement, or accept an early offer of $300,000 that the defendant knows does not reflect the case's real value. Pre-settlement funding changes this equation. An advance of $30,000 to $60,000 can cover a year or more of pressing expenses, giving the plaintiff the ability to hold out for the outcome his case actually warrants. The total cost of that funding -- perhaps $12,000 to $25,000 in fees by the time the case settles -- is far less than the hundreds of thousands he would have sacrificed by settling prematurely.

The application process for pre-settlement funding follows the same basic steps regardless of case type. You apply directly with a funding company (or ask your attorney to initiate the process on your behalf), the company reviews your case file, and if approved, sends funds to you directly. In most situations, you can have cash in your account within 24 to 48 hours of signing the funding agreement. There are no monthly payments required, no credit checks, and no employment verification.

What makes toxic tort underwriting somewhat distinct is the type of documentation needed. Because causation in these cases involves medical and scientific evidence rather than a police report or accident reconstruction, funding companies will typically want to review the following before making an approval decision:

• A confirmed diagnosis from a licensed physician linking your illness to a specific toxic substance
• Documentation of the exposure itself, such as employment records, military service records, residential history, or product identification records
• Your attorney's assessment of likely case value and expected timeline to resolution
• The current stage of litigation, whether you are pre-suit, in active discovery, or approaching a trial or settlement conference

Because many mesothelioma and asbestos cases involve well-documented corporate liability and established litigation history, they can actually underwrite more cleanly than cases where fault is genuinely disputed. A plaintiff with a confirmed mesothelioma diagnosis, documented employment at a shipyard or industrial facility, and representation by a specialized asbestos litigation firm presents a strong profile for approval.

One aspect of funding that every plaintiff should understand before signing is the cost structure. Funding companies charge a fee that accrues over time, typically structured as a monthly or semi-annual rate applied to the funded amount. If you receive $25,000 and your case settles 24 months later, you might repay anywhere from $38,000 to $50,000 depending on the company and the agreed rate. These numbers need to be clearly understood before you sign. Rates and terms vary significantly across funding companies, so comparing at least two or three agreements before committing is well worth the extra time.

Pre-settlement funding companies require your attorney's active cooperation to process an application. This requirement is standard across the industry. The funding company needs to independently verify the details of your case, confirm active legal representation, understand the likely recovery range, and establish a repayment mechanism that will be triggered when the case resolves. Attorneys are the appropriate party to provide this information because they hold the case file and have the professional relationship required to speak on your behalf.

Importantly, your attorney does not choose the funding company, does not endorse or recommend the specific terms of any agreement, and does not bear any financial responsibility for the funding. Their role is informational: they provide case documentation, answer the funding company's underwriting questions, and typically sign a limited letter of direction at settlement instructing that the funding repayment be made from settlement proceeds before the remainder is distributed to you. This protects the funding company's interest without placing any financial obligation on the attorney themselves.

Some attorneys are enthusiastic supporters of pre-settlement funding because they have seen firsthand how financial stability improves client outcomes and settlement values. Others treat it as a neutral administrative matter. A small number are skeptical, particularly if they have previously seen clients take excessive amounts of funding that complicated the final distribution at settlement. If your attorney is hesitant, a direct conversation about your financial situation, the specific amount you are requesting, and why you need it will usually resolve the concern. Most attorneys who understand the non-recourse structure and see the specific financial pressure their client faces will cooperate without difficulty.

The amount of pre-settlement funding available to you is directly tied to the estimated value of your case and the current stage of litigation. Funding companies typically advance between 10% and 20% of the estimated settlement or verdict value, though the exact percentage depends on the company's underwriting policies and how far along your case is. Cases that are closer to resolution -- at the summary judgment phase, in active settlement negotiations, or headed toward a near-term trial date -- can often access larger advances because the timeline to repayment is shorter and the outcome is more predictable.

For mesothelioma cases with strong liability, meaningful advances are often available. If your attorney estimates a likely settlement in the range of $800,000 to $1.5 million, an initial advance of $50,000 to $150,000 may be achievable. Not all of that needs to be taken at once. Many plaintiffs in long-running toxic tort cases request a moderate initial advance to address immediate needs and return for supplemental funding only if the case extends longer than anticipated.

For PFAS, Camp Lejeune, or broader mass tort cases where individual recovery amounts are harder to project -- especially when the case is part of an MDL proceeding with unknown individual allocations -- funding companies may take a more conservative approach. The uncertainty around individual payout timing and amount makes underwriting more complex, but approval remains possible when your attorney can provide reasonable documentation of your likely personal recovery range.

The most important guidance for any plaintiff is simple: request the minimum amount needed to cover your real financial obligations. Every dollar advanced will cost more than a dollar at repayment. Covering essential expenses such as housing, ongoing medical costs, food, and caregiving is a legitimate and reasonable use of pre-settlement funding. Taking a larger advance than necessary will reduce your net recovery at settlement. Be specific about what you need, discuss it openly with your attorney, and request only that amount.

What if I lose my case? If your case is dismissed or results in a defense verdict, you owe nothing to the funding company. Pre-settlement funding is non-recourse, meaning repayment is contingent solely on a successful outcome. This is the fundamental protection that distinguishes pre-settlement funding from a personal loan and makes it an appropriate option for plaintiffs who face genuine uncertainty about how their case will resolve.

Will this affect my credit score? No. Pre-settlement funding is not a loan and does not appear on your credit report. It will not affect your ability to qualify for other credit or housing. This is particularly important for toxic exposure plaintiffs who may have already depleted savings and damaged their credit through extended illness, reduced income, and mounting medical debt through no fault of their own.

Will the defendant find out I took funding? In most jurisdictions, pre-settlement funding agreements are private contracts that defense attorneys are not entitled to discover. Your decision to seek funding generally does not need to be disclosed in litigation and should not affect the conduct of your case in any way. If you have specific concerns about disclosure rules in your jurisdiction, your attorney can advise you on the applicable local rules.

How do I know if a funding company is legitimate? Reputable funding companies are transparent about rates and total cost before you sign, do not pressure you to decide immediately, and provide agreements written in plain language that clearly discloses the fee structure. Warning signs include companies that refuse to give written terms in advance, use confusing compounding rate language without a clear disclosure of total cost, or claim to guarantee approval before reviewing your case. A thorough review of any agreement before signing -- ideally with your attorney's input -- is the best protection against unfavorable terms.

Toxic exposure cases represent some of the most serious and consequential personal injury litigation in the American legal system. Mesothelioma, PFAS poisoning, benzene-related blood cancers, and lead poisoning are serious illnesses, often life-altering or terminal, caused by deliberate or negligent choices made by corporations and institutions that had reason to know better. The legal system can and does deliver meaningful compensation in these cases, but it does so slowly. And for the seriously ill plaintiffs at the center of this litigation, that time carries a heavy financial cost.

Pre-settlement funding will not cure an illness or accelerate the legal process. What it does is remove the financial desperation that forces plaintiffs to settle too early for too little. It gives you the stability to let your attorney do their job without the pressure of a depleted bank account or a landlord who cannot wait for your case to close. The ability to say no to a low offer because you can cover your expenses this month is worth far more than the cost of the funding itself.

If you or a family member is living with mesothelioma, a toxic exposure illness, or any serious injury while a personal injury case is pending, Levalera is ready to help you understand your options. The application process is straightforward, there are no upfront fees, and you will receive a clear answer quickly. A case specialist reviews your file directly with your attorney and can have funding to you within 24 to 48 hours of approval.